Clinical characteristics of patients who preferred migraine prevention treatment with CGRP monoclonal antibodies

被引：0
|
作者：
Vashchenko, N. [1 ,2 ]
Skorobogatykh, K. [2 ]
Azimova, J. [2 ]
Korobkova, D. [2 ]
机构：
[1] Sechenov Univ, Dept Neurol, Moscow, Russia
[2] Univ Headache Clin, Moscow, Russia
来源：
JOURNAL OF HEADACHE AND PAIN | 2021年 / 22卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0341
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [21] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
    Lovati, Carlo
    Bernasconi, Gianna
    Capogrosso, Chiara
    Molteni, Laura
    Giorgetti, Federica
    Dell'Osso, Bernardo
    Pantoni, Leonardo
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5765 - 5767
  • [22] Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention
    Schoenen, J.
    Manise, M.
    Nonis, R.
    Gerard, P.
    Timmermans, G.
    REVUE NEUROLOGIQUE, 2020, 176 (10) : 788 - 803
  • [23] CGRP Monoclonal Antibodies for Migraine: Rationale and Progress
    Hsiangkuo Yuan
    Clinton G. Lauritsen
    Eric A. Kaiser
    Stephen D. Silberstein
    BioDrugs, 2017, 31 : 487 - 501
  • [24] Review: An Update on CGRP Monoclonal Antibodies for the Preventive Treatment of Episodic Migraine
    Nicol, Kelly S.
    Burkett, John G.
    CURRENT PAIN AND HEADACHE REPORTS, 2025, 29 (01)
  • [25] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine
    Hennessy, Elise
    Salim, Amira
    Biswas, Sudipa
    Suneja, Aarushi
    Mays, Maryann
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
  • [26] CGRP Monoclonal Antibodies for Migraine: Rationale and Progress
    Yuan, Hsiangkuo
    Lauritsen, Clinton G.
    Kaiser, Eric A.
    Silberstein, Stephen D.
    BIODRUGS, 2017, 31 (06) : 487 - 501
  • [27] Synergism of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in the treatment of migraine
    Hennessy, E.
    Salim, A.
    Biswas, S.
    Sonneborn, C.
    Hogue, O.
    Suneja, A.
    Mays, M.
    Ahmed, Z.
    Mata, I
    HEADACHE, 2023, 63 : 170 - 171
  • [28] CGRP Monoclonal Antibodies: Targeted Migraine Treatment and Cardiovascular Safety Profile
    Boldig, Kimberly
    Butala, Nitin
    ANNALS OF NEUROLOGY, 2020, 88 : S148 - S149
  • [29] Early clinical response in patients with migraine in treatment with anti-CGRP monoclonal antibodies: a possible "loading dose" effect?
    Ceccardi, Giulia
    di Cola, Francesca Schiano
    Bolchini, Marco
    Di Pasquale, Michele
    Rao, Renata
    Padovani, Alessandro
    CEPHALALGIA, 2023, 43 (1supp) : 253 - 254
  • [30] "Triaging" Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
    Martelletti, Paolo
    PAIN AND THERAPY, 2020, 9 (02) : 349 - 351
12345